Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shuren's CDRH Sets Ambitious 2010 Agenda: 510(k), PMA Changes Planned

This article was originally published in The Gray Sheet

Executive Summary

CDRH launched an ambitious 2010 agenda Jan. 20 that includes changes to the 510(k) and PMA pre-market programs by this fall, harmonized international inspection activities by 2011 and unique device identifiers by 2013
Advertisement

Related Content

CDRH Explains New Process For Guidance Development
CDRH Slows Pace In 2011 Strategic Agenda, Focusing On Ongoing Efforts
Regulatory News In Brief
Industry Floats Idea Of User Fees For Reviewer Training
'Least Burdensome' Provisions Revisited In FDA Regulatory Science Report
Fed Council Seeks Easier Path For Devices Targeting Unmet Needs
Attendees Air 510(k) Concerns At CDRH Town Hall In Minnesota
Faster Than The Speed Of Guidance: FDA Explores New Ways To Issue Updates
FDA To Tackle Tough Pre-, Post-Market Issues At 510(k) Workshop
Chart: Device Center Initiatives Timeline

Topics

Advertisement
UsernamePublicRestriction

Register

MT028419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel